Some investors eager to cash in on Tesla‘s incredible rise seem to be buying the wrong stock. Tiziana Life Sciences, a tiny biotech firm with a ticker almost identical to Elon Musk’s car company, has miraculously pumped by 300% this year without generating any revenue at all. Tiziana Life Sciences, which trades under the $TLSA ticker, reportedly has no sales and just one analyst covering the company. Still, armed with a handful of press releases announcing partnerships with largely unknown biotech plays, its stock has somehow jumped from $2.80 to almost $11. [Watch Tesla’s meteoric rise — set to techno-remixed…

This story continues at The Next Web

Or just read more coverage about: Tesla